Want to know why we continue to spend so much more on healthcare than other countries? We have a price problem, one that experts predict will play a huge role in future healthcare spending:
If we want to reign in healthcare spending, we must go after high prices. That means taking on physicians, hospitals, pharma companies, device manufacturers…Any politicians ready to do that?
Lots of folks in the U.S. are finding themselves with health insurance coverage that requires them to pay lots of money, in their deductible, before insurance kicks in. Here is a nice piece in Cancer Today Magazine on the topic: Tammy Pope had already exceeded her health insurance plan’s $5,000 deductible for 2015 by August….
Lena Wright’s best friend was hunched over like a character from a French novel, with spinal bones so thin they would fracture with a fit of sneezing. Determined to avoid that fate, Wright (a pseudonym) asked her primary care doctor to test her for osteoporosis with a DEXA scan, also known as Dual Energy X-ray…
Shutterstock The last four decades have witnessed an explosion of thyroid cancer diagnoses in the U.S. People are three times more likely to receive cancer diagnoses now than they were in 1975. Why? Is it chemicals in the water supply? A side effect of all those childhood vaccines? Or is it because a TV ad…
We have experienced an impressive slowdown in the growth of healthcare expenditures in recent years, a slowdown attributed in part to the plethora of important drugs which have gone generic in recent years. But state Medicaid programs, according to a recent study in Health Affairs, could have slowed healthcare costs even more, if they had been quicker to switch patients from trade to…
Karen Scherr, an MD PhD student working with me, just published a paper showing that physicians don’t always give patients objective advice about the pros and cons of robotic surgery. Here is a news story on her work: Duke University research found that doctors are more enthusiastic about treatments that are readily available, calling into question…
Recently, pharmaceutical companies have been pricing many of their products at astounding values. A couple years ago, in fact, an amazing new hepatitis C drug came to market priced at about $90,000 per patient. But since that time, several other companies have come to market with competing products. That has brought the overall price of…